.png){kind=icon}
.png){kind=icon}
Return
Validity and Utility of a Single-Item Patient-Reported Measure of Treatment-Related Bother in Rheumatoid Arthritis: A Cross-Sectional OMERACT Study
.png){kind=icon}
OA
AI
D
T
M
P
L
J
C
M
M
P
B
D
J
R
T
S
G
R
DOI：10.1016/j.semarthrit.2026.152983.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• A single-item burden measure helped summarize patients’ experiences of side effects. • Patients’ overall bother from side effects are influenced by multiple symptoms. • Each symptomatic side effect has little impact on overall bother in RA patients.
Keywords:
OMERACT
Rheumatology
Harms
Safety
and Randomized Controlled Trials
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
4.4
Papers:
423
Citations:
1.0W
Organization
U
Cited Papers